Psychotropic Drugs and Sexual Dysfunction

References

• Aizenberg D., Zemishlany Z., Hermesh H., et al. Painful ejaculation associated with antidepressants in four patients. Journal of Clinical Psychiatry 1991; 52: 461–463
   PubMed Web of Science ®Google Scholar
• Altamura A. C., Montgomery S. A., Wernicke J. F. The evidence for 20 mg a day of fluoxetine as the optimal dose in the treatment of depression. British Journal of Psychiatry 1988; 153(Suppl. 3)109–112
   Web of Science ®Google Scholar
• Baier D., Philipp M. Effects of antidepressants on sexual function. Fortschritte der Neurologie Psychiatrie 1994; 62: 14–21
   PubMed Web of Science ®Google Scholar
• Baldwin D. S., Rudge S. E. The tolerability of moclobemide. Reviews in Contemporary Pharmacotherapy 1994; 5: 57–65
   Google Scholar
• Balogh S., Hendricks S. E., Kang J. Treatment of fluoxetine‐induced anorgasmia with amantadine [letter]. Journal of Clinical Psychiatry 1992; 53: 212–213
   PubMed Web of Science ®Google Scholar
• Bancroft J. Human Sexuality and its Problems2nd edition. Churchill Livingstone, Edinburgh 1989
   Google Scholar
• Barbeau A. L‐dopa therapy in Parkinson's disease: a critical review of nine years' experience. Canadian Medical Association Journal 1969; 101: 59–68
   PubMed Web of Science ®Google Scholar
• Barker D. (1995) Establishing that an association is causal. MRC Environmental Epidemiology Unit course on ‘Epidemiology for Clinicians’, Southampton, January, 1995
   Google Scholar
• Bartholomew A. A. A long acting phenothiazine as a possible agent to control deviant sexual behaviour. American Journal of Psychiatry 1968; 124: 917–923
   PubMed Web of Science ®Google Scholar
• Beaumont G. Sexual side‐effects of clomipramine [Anafranil]. International Medical Research 1977; 5: 37–44
   PubMed Web of Science ®Google Scholar
• Beck A. Depression. Clinical, experimental, and theoretical aspects. Staples Press, London 1967
   Google Scholar
• Beumont P. J. V., Geloer M. G., Friesen H. G., et al. The effects of phenothiazines on endocrine function. I. Patients with inappropriate lactation and amenorrhoea. British Journal of Psychiatry 1974; 124: 413–419
   PubMed Web of Science ®Google Scholar
• Bitran D., Hull E. M. Pharmacological analysis of male rat sexual behaviour. Neuroscience and Behavioural Research 1987; 11: 365–389
   PubMed Web of Science ®Google Scholar
• Cassidy W. L., Flanagan N. B., Spellman M., Cohen M. E. Clinical observations in manic depressive disease. Journal of American Medical Association 1957; 164: 1535–1546
   PubMed Web of Science ®Google Scholar
• Cohen A. J. Fluoxetine‐induced yawning and anorgasmia reversed by cyproheptadine treatment [letter]. Journal of Clinical Psychiatry 1992; 53: 174
   PubMed Web of Science ®Google Scholar
• Crisp A. H. Sexual psychopathology in the psychiatric clinic. British Journal of Clinical Practice 1979; 4: 3–11, supplement
   Google Scholar
• De Castro R. M. Reversal of MAOI‐induced anorgasmia with cyproheptadine [letter]. American Journal of Psychiatry 1985; 142: 783
   Web of Science ®Google Scholar
• Doogan D. P. Toleration and safety of sertraline: experience worldwide. International Clinical Psychopharmacology 1991; 6(supplement 2)47–56
   PubMedGoogle Scholar
• Dunbar G. C., Cohn J. B., Fabre L. F., Feighner J. P., Fieve R. R., Mendels J., Shrivastava R. K. A comparison of paroxetine, imipramine and placebo in depressed outpatients. British Journal of Psychiatry 1991; 159: 394–398
   PubMed Web of Science ®Google Scholar
• Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. Journal of Clinical Psychiatry 1991; 52: 163–164
   PubMed Web of Science ®Google Scholar
• Feighner J. P. A double‐blind comparison of paroxetine, imipramine and placebo in depressed outpatients. International Clinical Psychopharmacology 1992; 6(supplement 4)31–35
   PubMedGoogle Scholar
• Friedman S., Harrison G. Sexual histories, attitudes and behavior of schizophrenic and normal women. Archives of Sexual Behavior 1984; 13: 555–567
   PubMed Web of Science ®Google Scholar
• Gartrell N. Increased libido in women receiving trazodone. American Journal of Psychiatry 1986; 143: 781–782
   PubMed Web of Science ®Google Scholar
• Ghadirian A., Annabel L., Belanger M. C. Lithium, benzodiazepines and sexual function in bipolar patients. American Journal of Psychiatry 1992; 149: 801–805
   PubMed Web of Science ®Google Scholar
• Ghadirian A., Chouinard G., Annabel L. Sexual dysfunction and plasma prolactin levels in neuroleptic‐treated patients. Journal of Nervous and Mental Disease 1982; 170: 463–467
   PubMed Web of Science ®Google Scholar
• Gitlin M. J. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry 1994; 55: 406–413
   PubMed Web of Science ®Google Scholar
• Gittlesen N. L., Dawson‐Butterworth K. Subjective ideas of sexual change—female schizophrenics. British Journal of Psychiatry 1967; 113: 491–494
   PubMed Web of Science ®Google Scholar
• Gittlesen N. L., Levine S. Subjective ideas of sexual change in male schizophrenics. British Journal of Psychiatry 1966; 112: 779–782
   PubMed Web of Science ®Google Scholar
• Goldbloom D. S., Kennedy S. H. Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. Journal of Clinical Psychiatry 1991; 52: 261–262
   PubMed Web of Science ®Google Scholar
• Grisso. Making comparisons. Lancet. 1993
   PubMed Web of Science ®Google Scholar
• Gross M. D. Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants. American Journal of Psychiatry 1982; 139: 1193–1194
   PubMed Web of Science ®Google Scholar
• Harrison W. A., Rabkin J. G., Erhardt A., Stewart I. W., McGrath P. J., Ross D., Quitkin F. M. Effects of antidepressant medication on sexual function: a controlled study. Journal of Clinical Psychopharmacology 1986; 6: 144–149
   PubMed Web of Science ®Google Scholar
• Hawton K. Sex Therapy: A Practical Guide. Oxford University Press, Oxford 1985
   Google Scholar
• Herman J. B., Brotman A. W., Pollack M. H., Falk W. E., Biederman J., Rosenbaum J. F. Fluoxetine‐induced sexual function. Journal of Clinical Psychiatry 1990; 51: 25–27
   PubMed Web of Science ®Google Scholar
• Hirsch S. E., Barnes T. R. E. Clinical use of high‐dose neuroleptics. British Journal of Psychiatry 1994; 164: 94–96
   PubMed Web of Science ®Google Scholar
• Hollander E., McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. Journal of Clinical Psychiatry 1992; 53: 207–209
   PubMed Web of Science ®Google Scholar
• Jacobs H. S. Prolactin and sexual function. British Journal of Sexual Medicine 1979; 6: 3–6
   Google Scholar
• Jacobsen F. M. Fluoxetine‐induced sexual dysfunction and an open trial with yohimbine. Journal of Clinical Psychiatry 1992; 53: 168–172
   Web of Science ®Google Scholar
• Jenner P. N. Paroxetine: an overview of dosage, tolerability and safety. International Clinical Psychopharmacology 1992; 6(supplement 4)69–80
   PubMedGoogle Scholar
• Kogeorgas J., de Alwis C. Priapism and psychotropic medication. British Journal of Psychiatry 1986; 149: 241–243
   PubMed Web of Science ®Google Scholar
• Kraupl T. F. Loss of libido in depression. British Medical Journal 1972; 1: 305
   Google Scholar
• Lal S., Guyda H., Bikadoroff S. Effect of methysergide and pimozide on apomorphine‐induced growth hormone secretion in men. Journal of Clinical Endocrinology and Metabolism 1977; 44: 766–770
   PubMed Web of Science ®Google Scholar
• Lal S., Nair N. P. V., Iskander H. L., et al. Effect of domperidone on apomorphine‐induced growth hormone secretion in normal men. Journal of Neural Transmission 1982; 54: 75–84
   PubMed Web of Science ®Google Scholar
• Lieberman J. A., Kane J. M., Johns C. A. Clozapine: guidelines for clinical management. Journal of Clinical Psychiatry 1989; 50: 329–338
   PubMed Web of Science ®Google Scholar
• Lydiard R. B., Howell F. F., Laraia M. T., et al. Sexual side effects of alprazolam [letter]. American Journal of Psychiatry 1987; 144: 254–255
   PubMed Web of Science ®Google Scholar
• Mathew R. J., Weinman M. L. Sexual dysfunction in depression. Archives of Sexual Behaviour 1982; 11: 323–328
   PubMed Web of Science ®Google Scholar
• Mathew R. J., Weinman M. L., Cleghorn J. L. Tricyclic side effects without tricyclics in depression. Psychopharmacology Bulletin 1980; 16: 53–60
   PubMedGoogle Scholar
• McCormick S., Olin J., Brotman A. W. Reversal of fluoxetine‐induced anorgasmia by cyproheptadine in two patients. Journal of Clinical Psychiatry 1990; 51: 383–384
   PubMed Web of Science ®Google Scholar
• McLean J. G., Forsythe R. G., Kapkin I. A. Unusual side effects of clomipramine associated with yawning. Canadian Journal of Psychiatry 1983; 28: 569–570
   PubMed Web of Science ®Google Scholar
• Mitchell J. E., Popkin M. K. Antidepressant drug therapy and sexual dysfunction in men: a review. Journal of Clinical Psychopharmacology 1983; 3: 76–80
   PubMed Web of Science ®Google Scholar
• Modell J. G. Repeated observations of yawning, clitoral engorgement and orgasm associated with fluoxetine administration [letter]. Journal of Clinical Psychiatry 1989; 9: 63–65
   Google Scholar
• Monteiro W. O., Norshivani H. F., Marks I. M., Lelliot P. T. Anorgasmia from clomipramine in obsessive‐compulsive disorder. A controlled trial. British Journal of Psychiatry 1987; 151: 107–112
   PubMed Web of Science ®Google Scholar
• Montgomery S. A., Baldwin D. S., Fineberg N. A. The relative toxicity of antidepressants using reports independent of observer bias. Neuropsychopharmacology 1990; 580–584
   Google Scholar
• Musher J. S. Anorgasmia with the use of fluoxetine [letter]. American Journal of Psychiatry 1990; 147: 948
   PubMed Web of Science ®Google Scholar
• Nathan S. G. Spontaneous resolution of MAOI‐induced anorgasmia. American Journal of Psychiatry 1988; 145: 134–135
   PubMed Web of Science ®Google Scholar
• Neill J. R. Penile anaesthesia associated with fluoxetine [letter]. American Journal of Psychiatry 1991; 148: 1603
   PubMed Web of Science ®Google Scholar
• Nelson R. P. Non‐operative management of impotence. Journal of Urology 1987; 137: 1168–1172
   PubMedGoogle Scholar
• Nesteros J. N., Lehmann H. E., Ban T. A., et al. Sexual behaviour of the male schizophrenic: the impact of illness and medications. Archives of Sexual Behaviour 1981; 10: 421–442
   PubMed Web of Science ®Google Scholar
• Nofzinger E. A., Thase M. E., Reynolds C. F., et al. Sexual function in depressed men: assessment by self‐report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Archives of General Psychiatry 1993; 50: 24–30
   PubMed Web of Science ®Google Scholar
• Nurnberg H. G., Levine P. E. Spontaneous remission of MAOI‐induced anaorgasmia. American Journal of Psychiatry 1987; 144: 805–807
   PubMed Web of Science ®Google Scholar
• Patterson W. M. Fluoxetine‐induced sexual dysfunction. Journal of Clinical Psychiatry 1993; 54: 71
   PubMed Web of Science ®Google Scholar
• Philipp M. R., Kohnen R., Benkert D. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. International Clinical Psychopharmacology 1993; 7: 123–132
   Web of Science ®Google Scholar
• Pollack M. H., Rosenbaum J. F. Management of antidepressant‐induced side effects: a Practical guide for the clinician. Journal of Clinical Psychiatry 1987; 48: 3–8
   PubMed Web of Science ®Google Scholar
• Price J., Grunhaus L. J. Treatment of clomipramine‐induced anorgasmia with yohimbine: a case report. Journal of Clinical Psychiatry 1990; 51: 32–33
   PubMed Web of Science ®Google Scholar
• Rees J. M. H. Sexual dysfunction and prescribed psychotropic drugs. Psychopharmacology and Sexual Disorders, D. Wheatley. Oxford University Press, Oxford 1983; 138–147
   Google Scholar
• Rees S. H. 1992, Personal communication, 27th April, 1992
   Google Scholar
• Reid K., Morales A., Herris C., et al. Double‐blind trial of yohimbine in treatment of psychogenic impotence. Lancet 1987; 2: 421–423
   PubMed Web of Science ®Google Scholar
• Reimherr F. W., Chouinard G., Cohn C. K., Cole J. O., Itil T. M., La Pierre Y. D., Masco H. L., Mendels J. Antidepressant efficacy of sertraline: a double‐blind, placebo‐ and comparator‐controlled multicenter comparison study in outpatients with major depression. Journal of Clinical Psychiatry 1990; 51(12)18–27, supplement B
   PubMed Web of Science ®Google Scholar
• Riley A. J., Riley E. J. The effects of single dose diazepam on female sexual response induced by masturbation. Sexual and Marital Therapy 1986; 1: 49–54
   Google Scholar
• Riley A. J., Riley E. J. Cyproheptadine and antidepressant‐induced anorgasmia [letter]. British Journal of Psychiatry 1986; 148: 217–218
   PubMed Web of Science ®Google Scholar
• Roose S. P., Glassman A. H., Walsh B. T., Cullen K. Reversible loss of nocturnal penile tumescence during depression: a preliminary report. Neuropsychobiology 1982; 8: 284–288
   PubMed Web of Science ®Google Scholar
• Sangal R. Inhibited female orgasm as a side effect of alprazolam [letter]. American Journal of Psychiatry 1985; 142: 1223–1224
   PubMed Web of Science ®Google Scholar
• Schreiner‐Engel P., Schiavi R. C. Lifetime psychopathology in individuals with low sexual desire. Journal of Nervous and Mental Diseases 1986; 174: 646–651
   PubMed Web of Science ®Google Scholar
• Schwartz M. F., Bauman J. E., Masters W. H. Hyperprolacrinaemia and sexual disorders in men. Biological Psychiatry 1982; 17: 861–876
   PubMed Web of Science ®Google Scholar
• Segraves R. T. Effects of psychotropic drugs on human erection and ejaculation. Archives of General Psychiatry 1989; 46: 275–284
   PubMed Web of Science ®Google Scholar
• Shukla G., Srivastava O., Katiyar B. Sexual disturbance in temporal lobe epilepsy: a controlled study. British Journal of Psychiatry 1979; 134: 288–292
   PubMed Web of Science ®Google Scholar
• Sitland‐Marken P. A., Wells B. G., Froemming J. H., et al. Psychiatric applications of bromocriptine therapy. Journal of Clinical Psychiatry 1990; 51: 68–82
   PubMed Web of Science ®Google Scholar
• Sorscher S. M., Dilsaver S. C. Antidepressant‐induced sexual dysfunction in men: due to cholinergic blockade?. Journal of Clinical Psychopharmacology 1986; 6: 53–55
   PubMed Web of Science ®Google Scholar
• Sovner R. Anorgasmia associated with imipramine but not with desipramine: case report. Journal of Clinical Psychiatry 1983; 44: 345–346
   PubMed Web of Science ®Google Scholar
• Sovner R. Treatment of tricyclic antidepressant‐induced orgasmic inhibition with cyproheptadine [letter]. Journal of Clinical Psychopharmacology 1984; 4: 169
   PubMed Web of Science ®Google Scholar
• Stark P., Hardison C. D. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 53–58
   PubMed Web of Science ®Google Scholar
• Steele T. E., Howell E. F. Cyproheptadine for imipramine‐induced anorgasmia [letter]. Journal of Clinical Psychopharmacology 1986; 6: 326–327
   PubMed Web of Science ®Google Scholar
• Sullivan G. Increased libido in three men treated with trazodone. Journal of Clinical Psychiatry 1988; 49: 202–203
   PubMed Web of Science ®Google Scholar
• Sullivan G., Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hospital and Community Psychiatry 1990; 41: 1238–1241
   PubMedGoogle Scholar
• Swan M., Wilson L. J. Sexual and marital problems in a psychiatric outpatient population. British Journal of Psychiatry 1979; 135: 310–314
   PubMed Web of Science ®Google Scholar
• Taylor D. C. Sexual behaviour and temporal lobe epilepsy. Archives of Neurology 1969; 21: 510–516
   PubMed Web of Science ®Google Scholar
• Tennent G., Bancroft J., Cass P. The control of deviant sexual behaviour by drugs: a double‐blind controlled study of benperidol, chiorpromazine and placebo. Archives of Sexual Behaviour 1974; 3: 261–271
   PubMed Web of Science ®Google Scholar
• Thase M. E., Reynolds C. F., Glanz L. M., et al. Nocturnal penile tumescence in depressed men. American Journal of Psychiatry 1987; 144: 89–92
   PubMed Web of Science ®Google Scholar
• Thase M. E., Reynolds C. F., Jennings R., et al. Nocturnal penile tumescence is diminished in depressed men. Biological Psychiatry 1988; 24: 33–46
   PubMed Web of Science ®Google Scholar
• Thase M. E., Reynolds C. F., Jennings R., Frank E., Garamoni G. L., Nofzinger E. A., Fascizka A. L., Kupfer D. J. Diminished noctur‐nalpenile tumescence in depression: a replication study. Biological Psychiatry 1992; 31: 1136–1142
   PubMed Web of Science ®Google Scholar
• Thompson J. W., Jr, Ware M. R., Blashfield R. K. Psychotropic medication and priapism: a comprehensive review. Journal of Clinical Psychiatry 1990; 51: 430–433
   PubMed Web of Science ®Google Scholar
• Wandzel L., Falicki Z. Reversal by bethanechol of imipramine‐induced ejaculatory dysfunction [letter]. American Journal of Psychiatry 1987; 144: 1243–1244
   PubMed Web of Science ®Google Scholar
• Watson J. P. Sexual behaviour, relationship and mood. British Journal of Clinical Practice 1979; 4: 23–26, supplement
   Google Scholar
• Woodruff R. A., Murphy G. E., Herjanic M. The natural history of affective disorders: I. Symptoms of 72 patients at the time of index hospital admission. Journal of Psychiatric Research 1967; 5: 255–263
   PubMed Web of Science ®Google Scholar
• Yager J. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report. Journal of Clinical Psychiatry 1986; 47: 210–211
   PubMed Web of Science ®Google Scholar
• Yeragani V. K., Pohl R., Balon R. Sexual dysfunction related to alprazolam treatment of social phobia [letter]. American Journal of Psychiatry 1988; 145: 531–532
   PubMed Web of Science ®Google Scholar
• Zajecka J., Fawcett J., Schaff M., Jeffries H., Guy C. The role of serotonin in sexual dysfunction: fluoxetine‐associated orgasm dysfunction. Journal of Clinical Psychiatry 1991; 52: 66–68
   PubMed Web of Science ®Google Scholar
• Zubieta J. K., Demitrack M. A. Depression after cyproheptadine: MAOI treatment. Biological Psychiatry 1992; 31: 1177–1178
   PubMed Web of Science ®Google Scholar